To mark Brain Awareness Week (March 14th – 20th), MS Ireland have invited Dr Claire McCoy and Dr Lisa Costelloe to join us on a webinar to discuss their thoughts on the recent EBV study from Harvard University. The paper titled ‘Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis’ which was recently published involved 10 million young adults in the US military. It showed that the risk of getting MS is increased 32-fold after infection with EBV. In previous research on EBV and MS a casual link was shown. However, in this study, neurofilaments (a marker of neurodegeneration), were shown to rise in those who would go on to develop MS, only after EBV infection. This tells us that you must be infected with EBV first, prior to developing MS. This crucial finding is compelling evidence for us to carry out a definitive study to prove that EBV is the cause of MS.
This webinar will allow the MS community to hear the dual perspective from both a research scientist and a consultant neurologist.
The webinar will take place on Wednesday March 16th from 4 -5 pm. The session will be recorded and available on our website within a week of recording.
Registration for the live event is required. You can register here:
After registering, you will receive a confirmation email containing information about joining the webinar.
Dr Claire McCoy is a research scientist and senior lecturer in immunology at the Royal College of Surgeons in Ireland. She leads a research team investigating the impact of the immune system in Multiple Sclerosis, with the aim to understand how manipulation of the immune system may be therapeutically harnessed for the treatment of MS. Claire has published 26 manuscripts in high impact journals and is the recipient of multiple national and international research awards, most notably; the President of Ireland Future Research Leader Award from Science Foundation Ireland. She co-founded the All-Ireland MS Research Network and acts as a scientific advisor for MS Ireland and FutureNeuro.
Dr Lisa Costelloe is a graduate of UCD Medical school and is a Consultant Neurologist in Beaumont Hospital since 2012. She is the Chair of Neurology in Beaumont Hospital, a national neuroscience centre. She is an honorary Senior clinical Lecturer in both RCSI and TCD. Her area of clinical and research interest is Multiple Sclerosis (MS) and she has published widely in the areas of clinical outcome measurements and in immunological aspects of MS and has completed an MD thesis in this area in UCD. She is a principal investigator in a number of MS clinical trials and sits on several steering committees and advisory boards both nationally and internationally.